Gene Query: CYB5A

Dataset Description Geneva Score
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 77.48
Role of CD133 molecule in WNT response and renal repair 60.29
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 46.27
HNF1 regulates critical functions of the human epididymis epithelium. 46.27
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 34.43
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 32.47
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 32.47
Lipid degradation promotes prostate cancer cell survival 29.47
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 28.43
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 28.19
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 28.19
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 28.04
Global expression profiles in cardiac progenitor cells generated by ISX-9 24.95
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 24.95
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 23.23
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 22.57
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 22.57
Chromatin landscape of human visceral and subcutaneous adipocytes 22.25
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 22.21
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 22.04
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 21.92
DIGIT regulates endoderm differentiation of human embryonic stem cells 21.55
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 21.12
BAF controls genome accessibility 20.0
Transcriptome analysis of kidney organoids 19.8
Changes in human endometrial gland transcriptome over the window of implantation 19.53
The Genomic Landscape of Atypical Fibroxanthoma 18.48
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 18.16
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 18.16
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 17.97
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 17.74
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 17.59
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 17.58
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 17.36
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 17.36
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 17.32
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 17.18
Identification of transcription start sites for human A549 cell line using ReCappable-seq 16.97
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 16.68
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 16.4
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 16.4
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 16.25
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 16.25
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 16.08
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 15.66
RNA-seq analyses of human prostate cancer cells 15.42
IL-33 activates tumor stroma to promote intestinal polyposis 15.25
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 15.1
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 14.92
The comparison of high-throughput single-cell RNA-seq methods 14.89
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 14.87
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 14.35
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 14.35
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 14.28
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 14.24
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 14.21
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 14.2
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 13.97
Single-nucleotide-resolution mapping of HBV promoters using CAGE 13.96
An RNA-centric dissection of host complexes controlling flavivirus infection 13.7
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 13.7
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 13.36
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 13.11
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 13.11
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 12.93
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 12.84
Expression patterns in chronic thromboembolic pulmonary hypertension 12.82
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 12.62
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 12.61
Loss of endometrial plasticity in recurrent pregnancy loss 12.61
RNA-seq analysis of the human fetal kidney. 12.57
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 12.55
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 12.55
TGF-β promotes genomic instability after loss of RUNX3 12.52
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 12.45
Tyrosine Kinase Inhibitor Cardiotoxicity 12.35
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 12.35
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 12.21
HNF1A deficiency impairs β-cell fate, granule maturation and function 12.2
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 12.17
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 12.1
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 12.05
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 12.0
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 11.99
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 11.95
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 11.91
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.84
RNAseq of T-ALL upon long non coding rna purturbation 11.81
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 11.78
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 11.76
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 11.75
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 11.65
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 11.65
mRNA differential expression analysis in a human ex vivo model of chronic wounds 11.57
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 11.41
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 11.4
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 11.34
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 11.34
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 11.33
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 11.31
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 11.29
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 11.2
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 11.19
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 11.15
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 11.11
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 11.11
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 11.1
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 10.88
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 10.8
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 10.79
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 10.79
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 10.77
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 10.77
Gene expression patterns define the hepatocyte-like cells derived by different strategies 10.54
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 10.54
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 10.49
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 10.49
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 10.47
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 10.43
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 10.42
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 10.41
Identifying the molecular mode of action of itraconazole in colorectal cancer 10.37
Transcriptome profiling of Normal and Cancerous Prostate Cells 10.35
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 10.25
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 10.25
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 10.14
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 10.13
TOP2B disturbed the quality of human oocytes with advanced maternal age 10.1
Epigenomic landscape during organ formation in human early embryos 10.09
H1609088 Human RNA-Sequencing 9.95
The expression profiles of GBC liver metastasis 9.9
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 9.79
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 9.77
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 9.77
Identification of HOXB13 target genes responsive to BET inhibitors 9.69
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.66
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 9.61
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 9.6
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 9.58
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 9.42
Reprogrammed myeloid cell transcriptomes in NSCLC 9.2
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 9.12
RNA-seq data from human lymphoma cell lines 9.07
ChIP-seq and RNA-seq from human lymphoma cell lines 9.07
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 8.96
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 8.94
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 8.91
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 8.88
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 8.88
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 8.8
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 8.79
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.79
CROP-Seq in Primary Human T Cells 8.78
Transcriptome analysis of SKI knock-out in HL60 cells 8.72
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 8.72
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 8.63
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 8.61
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 8.6
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 8.59
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 8.58
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 8.58
Gene expressions of H9s in different culture systems 8.56
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 8.52
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 8.52
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 8.5
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 8.49
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 8.43
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 8.43
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 8.4
AR-independent prostate cancer is sustained through FGF signaling 8.38
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 8.32
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 8.31
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 8.25
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 8.25
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 8.24
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 8.23
Clinker: visualizing fusion genes detected in RNA-seq data 8.15
Dtx3L and Androgen Signaling in Prostate Cancer 8.02
Total RNA sequencing of WT intestinal orgaonids. 8.02
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 8.0
CHD1 regulates cell fate determination by activation of differentiation-induced genes 7.98
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 7.98
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 7.98
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.97
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 7.94
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 7.93
Overexpression of NFIB and YBX1 in MCF-7 cells 7.93
Transciptomic profiling of human fetal lung samples 7.92
Gene expression signatures of innate lymphoid cells from human blood 7.9
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 7.85
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 7.85
A prostate cancer chromatin interaction map 7.85
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 7.84
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 7.84
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 7.81
AUF-1 affected genes in human skin cells 7.81
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 7.75
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 7.67
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 7.64
mRNA-Seq profiling of human developing kidney 7.62
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.58
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 7.57
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 7.51
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 7.51
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 7.51
Regulation of highly expressed hCINAP on translatome 7.46
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 7.44
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 7.44
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 7.35
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 7.32
Ro60-knockout cells 7.26
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 7.24
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.23
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 7.21
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 7.21
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 7.21
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 7.18
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 7.06
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 7.06
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 7.05
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.01
Transcriptome of human white and brown adipose tissue biopsies 7.0
RNA-Seq with and without RNase treatment in PCa cell lines 7.0
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 6.97
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 6.97
GATA3-mediated chromatin reprogramming in breast cancer cells 6.97
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 6.96
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 6.91
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 6.89
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 6.85
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 6.82
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 6.82
scRNASeq analysis of cycling cardiomyocytes 6.76
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 6.75
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 6.75
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 6.75
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 6.75
Gene expression analysis of immortalized human liver progenitor-like cells in culture 6.72
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 6.71
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 6.71
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 6.7
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 6.69
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 6.65
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.63
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 6.59
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 6.56
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 6.55
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 6.55
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 6.53
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 6.51
Effect of CHKA knockdown on C4-2 cell transcriptome 6.51
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 6.48
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.44
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 6.42
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 6.42
Repurposing of promoters and enhancers during mammalian evolution 6.42
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 6.42
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 6.38
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 6.36
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 6.31
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 6.31
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.31
Paxillin regulates genomic networks in prostate cancer [PC3] 6.31
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 6.25
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 6.25
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.22
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 6.22
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 6.21
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 6.19
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 6.17
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.12
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 6.05
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 6.04
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 6.01
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 5.94
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.94
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 5.92
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 5.89
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 5.89
Next generation sequencing of small RNAs isolated from exosomes in human semen 5.87
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 5.82
STX4 Over-Expression in Human islets 5.78
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 5.77
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 5.77
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.74
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 5.7
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.69
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 5.69
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 5.68
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 5.66
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 5.62
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 5.61
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 5.6
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 5.58
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 5.52
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 5.41
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 5.39
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 5.37
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 5.34
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 5.29
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 5.25
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 5.25
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 5.25
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.24
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 5.19
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 5.17
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 5.16
Patient-derived luminal breast cancer xenografts with progestins 5.16
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 5.13
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 5.13
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 5.08
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 4.93
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.8
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 4.77
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.72
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.69
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 4.67
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 4.64
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 4.64
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 4.61
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 4.6
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 4.58
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.57
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 4.53
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 4.47
Identification of Sin3B regulated genes during quiescence 4.47
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 4.46
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 4.42
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 4.38
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 4.35
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 4.3
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 4.23
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 4.23
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 4.19
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 4.18
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 4.16
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 4.16
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 4.13
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 4.11
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.09
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.09
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.09
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.04
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.04
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.03
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.03
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.02
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 4.0
Hepatocyte maturation 3.97
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 3.91
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 3.9
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 3.83
Identification of expressed and conserved human non-coding RNAs 3.8
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 3.72
Gene profiling of human adult and pediatric liver cancer cells 3.72
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 3.65
Persistence of stem cell metabolism in cancers as a failure of differentiation 3.63
Effect of PBK knockdown on C4-2 cell transcriptome 3.59
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 3.56
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 3.55
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 3.55
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 3.53
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 3.53
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.53
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 3.53
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 3.51
ML29755 RNA-seq data 3.45
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.45
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 3.39
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.32
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 3.26
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 3.26
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.25
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 3.25
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.17
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 3.13
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.13
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 3.1
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.1
Human islets of varying quality: the good, the (not so) bad and the ugly 2.96
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 2.91
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 2.89
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 2.86
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.82
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.82
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 2.79
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.78
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 2.73
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.69
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 2.68
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 2.64
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 2.6
iPSC-Derived Cholangiocytes 2.6
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 2.58
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 2.57
Human ovarian granulosa cell transcriptome 2.52
The gene expression profiles of gallbladder cancer 2.48
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 2.45
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 2.45
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.43
LIN28A Over-expression RNAseq 2.42
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.41
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.39
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.34
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.34
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 2.31
JAK dependent survival of ALK- ALCL 2.28
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 2.25
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 2.22
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.19
The transcriptome of Kawasaki Disease arteritis 2.14
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.12
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.87
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.86
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.86
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.83
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 1.79
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.77
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.77
RNAseq of Breast cancer PDX samples 1.69
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.67
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.64
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 1.61
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.56
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.56
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.55
An integrative analysis of non-coding regulatory DNA variations associated with autism 1.49
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.43
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 1.43
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.41
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.4
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.39
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.39
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.36
Dermal endothelial cells of type 2 diabetic patients 1.34
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.33
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.33
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 1.32
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 1.31
A single-cell transcriptome atlas of the human pancreas 1.26
Gene expression of collecting duct carcinoma of the kidney 1.24
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.16
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.12
Transcriptomic analysis of frontal fibrosing alopecia 1.12
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.07
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.07
Polarized B -cell functions 1.06
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.02
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.02
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 1.01
KSDM1b Role in Ewing Sarcoma 0.96
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.96
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.96
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 0.91
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.91
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.9
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 0.86
Identification of long noncoding RNAs in T-ALL cell lines 0.84
Gene expression alterations of pancreatic intraepithlial neoplasia 0.83
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 0.81
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.78
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.78
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.72
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.71
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.7
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.68
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.61
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.61
p63 controls the enhancer landscape during keratinocyte differentiation 0.53
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.52
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.52
RNA-Seq and expression data from human adipose tissue 0.5
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.5
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.46
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.46
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.45
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.45
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.4
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 0.33
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.27
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.27
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.26
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.25
RNAseq analysis of ruxolitinib treated breast cancers 0.2
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.19
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 0.18
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 0.18
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.18
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.16
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.16
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.15
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.14
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.12
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 0.1
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.05
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.05
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.04
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.03
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.01
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation